Status:
UNKNOWN
Anesthetic Premedication With a Cannabis Extract (Cannapremed)
Lead Sponsor:
Hadassah Medical Organization
Collaborating Sponsors:
Jazz Pharmaceuticals
Conditions:
Pain, Postoperative
Postoperative Nausea and Vomiting
Eligibility:
All Genders
18-60 years
Phase:
PHASE2
PHASE3
Brief Summary
Clinical evidence about the effects of cannabis in a perioperative setting or for the management of acute pain is rather scarce, mostly consisting of case report-based opinions on adverse events durin...
Detailed Description
The selection of patients will be done during the pre-anesthetic assessment the day before surgery. After obtaining informed consent, eligible patients will be randomly allocated to one of the followi...
Eligibility Criteria
Inclusion
- Patients scheduled for elective surgeries suitable for postoperative pain treatment with intravenous morphine patient-controlled analgesia.
- American Society of Anesthesiologist (ASA) risk I or II
Exclusion
- ASA III or higher
- Cannabis use within the last 6 months
- Pregnancy
- Emergency surgeries
- Regional anesthesia
- Ischemic heart disease
- Renal failure
- History of psychosis
- Cognitive impairment or inability to answer questions
Key Trial Info
Start Date :
May 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02283281
Start Date
May 1 2015
End Date
December 1 2024
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hasassah - Hebrew University Ein Kerem Medical Center
Jerusalem, Israel, 12000